Interventional Lung Solutions Market Growth Outlook Reveals A CAGR Of 8.1% And A Market Value Of $3.65 Billion By 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Interventional Lung Solutions Market Expected To Reach $3.65 Billion By 2030 At 8.1% CAGR
The market for interventional lung solutions has experienced robust expansion over recent years, with projections indicating an increase from $2.47 billion in 2025 to $2.68 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.3%. This historical growth has been driven by a higher incidence of COPD and lung cancer, constraints associated with surgical lung interventions, progress in bronchoscopy technology, growing use of minimally invasive techniques in hospitals, and an overall rise in healthcare spending.
The interventional lung solutions market is projected to experience robust expansion in the coming years, reaching $3.66 billion by 2030 at a compound annual growth rate (CAGR) of 8.1%. This forecasted growth is driven by an increasing elderly population suffering from respiratory conditions, a greater uptake of robotic-assisted interventions, an expansion in outpatient pulmonary procedures, a heightened emphasis on early lung cancer detection, and progress in navigation bronchoscopy technology. Key trends shaping the market during this period include a growing preference for minimally invasive pulmonary techniques, a higher utilization of robotic bronchoscopy systems, an increased demand for lung volume reduction devices, an expansion in image-guided interventional lung therapies, and a rising preference for disposable bronchoscopes.
Download A Free Sample Report For Comprehensive Market Insights:
Interventional Lung Solutions Market Demand Drivers Creating New Revenue Opportunities
The projected expansion of the interventional lung solutions market is being driven by the rising incidence of respiratory diseases. These diseases encompass various medical conditions that impair lung and airway function, leading to breathing difficulties and disrupted respiratory processes. This upward trend in respiratory illnesses is largely attributed to worsening air pollution, which results in sustained exposure to dangerous airborne substances and irritants. Through minimally invasive techniques, interventional lung solutions assist in managing such conditions by enhancing lung performance and alleviating symptoms in patients suffering from chronic pulmonary disorders. As an example, BioMed Central Ltd, a UK-based journal platform, reported in May 2025 that the global prevalence of chronic obstructive pulmonary disease stands at 10.3%, with an anticipated 600 million individuals affected by 2050. Additionally, asthma currently impacts around 262 million people worldwide. Consequently, the growing frequency of respiratory diseases is propelling the interventional lung solutions market forward.
Interventional Lung Solutions Market Segment Analysis Highlighting Growth Areas
The interventional lung solutions market covered in this report is segmented –
1) By Product Type: Bronchoscopes, Endobronchial Ultrasound Needles, Pleuroscopes, Airway Stents, Other Product Types
2) By Technology: Robotic Surgery, Laser Therapy, Electromagnetic Navigation Bronchoscopy
3) By Procedure: Bronchoscopy, Thoracoscopy, Pleuroscopy, Other Procedures
4) By Application: Lung Cancer Treatment, Chronic Obstructive Pulmonary Disease
5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) BY Bronchoscopes: Flexible Bronchoscopes, Rigid Bronchoscopes, Disposable Bronchoscopes
2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles, Biopsy Needles
3) By Pleuroscopes: Flexible Pleuroscopes, Semi-Rigid Pleuroscopes
4) By Airway Stents: Metallic Stents, Silicone Stents, Hybrid Stents
5) By Other Product Types: Bronchial Thermoplasty Devices, Lung Volume Reduction Devices, Electromagnetic Navigation Systems, Cryotherapy And Ablation Devices
Interventional Lung Solutions Market Trends Driving Strategic Industry Expansion
Major players in the interventional lung solutions sector are concentrating on advancing cutting-edge technologies like the Ion Endoluminal System to boost lung cancer diagnostic precision, facilitate minimally invasive treatments, and improve patient recovery through enhanced navigation and biopsy features. The Ion Endoluminal System represents a robotic-assisted tool intended for low-impact lung procedures, offering accurate airway navigation to target small or challenging lung nodules. As an example, in April 2024, H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a nonprofit entity based in the United States, unveiled a new Ion Robotic Bronchoscopy platform, strengthening their interventional pulmonology program with sophisticated fiber-optic technology and a minimally invasive catheter system. This innovation employs fiber optics and the industry’s smallest catheter to access all lung regions. The platform includes an extremely thin, highly flexible catheter capable of 180° movement, integrated live visual feedback, and shape-sensing capabilities, allowing exact navigation and sample collection from difficult-to-reach peripheral lung nodules. This setup delivers unmatched steadiness and accuracy for tissue extraction, enabling clinicians to access every one of the 18 lung segments and boosting early-stage lung cancer identification.
Interventional Lung Solutions Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., EndoMed Systems GmbH
Access The Complete Interventional Lung Solutions Market Report:
Interventional Lung Solutions Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the interventional lung solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional lung solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
